Hexagon Bio
PrivateLast Round
Series B
Feb 13, 2023
Total Funding Raised
$132.6M
Company Overview
Hexagon Bio is a biotechnology company that utilizes a synthetic biology platform and data science to discover small molecule inhibitors from fungal genomes, facilitating the identification of new medicines to enhance patient care.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hexagon Bio Comparables
Compare Hexagon Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LifeMine Therapeutics | 83% | |
| Bactobio | 80% | |
| Pragma Bio | 80% | |
Hexagon Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 13, 2023 | ||||
| VC Round | Sep 22, 2021 | ||||
| Series A | Sep 15, 2020 | ||||
| Seed | Jul 6, 2017 |
Hexagon Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | VC Round, Series B, Series A |
| CPP Investments | Series B |
| SoftBank Investment Advisers | VC Round |
| SoftBank Group | VC Round |
| The Chernin Group | Series A |
| Two Sigma Ventures | VC Round, Seed, Series B, Series A |
| 8VC | VC Round, Seed, Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 17, 2025
Developing natural crop protections in partnership with Corteva.
- Dec 17, 2025
Partnered with Corteva to develop natural crop protections.
Hexagon Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hexagon Bio's valuation, stock price, and market status.